TELA Bio, Inc. (TELA) Insider Trading Activity

NASDAQ$0.8834+0.08 (9.98%)
Market Cap
$36.21M
Sector
Healthcare
Industry
Medical—Devices
Rank in Sector
72 of 849
Rank in Industry
12 of 107

TELA Insider Trading Activity

TELA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$4,186,456
7
100
Sells
$0
0
0

Related Transactions

EW HEALTHCARE PARTNERS FUND 2, L.P.See Remarks
1
$4M
0
$0
$4M
Capper Joseph Hdirector
4
$167,238
0
$0
$167,238
Getz Heather CChief Executive Officer
2
$18,778
0
$0
$18,778

About TELA Bio, Inc.

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile …

Insider Activity of TELA Bio, Inc.

Over the last 12 months, insiders at TELA Bio, Inc. have bought $4.19M and sold $0 worth of TELA Bio, Inc. stock.

On average, over the past 5 years, insiders at TELA Bio, Inc. have bought $9.54M and sold $1.91M worth of stock each year.

Highest buying activity among insiders over the last 12 months: EW HEALTHCARE PARTNERS FUND 2, L.P. (See Remarks) — $4M. Capper Joseph H (director) — $167,238. Getz Heather C (Chief Executive Officer) — $18,778.

The last purchase of 25,000 shares for transaction amount of $30,530 was made by Capper Joseph H (director) on 2026‑09‑17.

List of Insider Buy and Sell Transactions, TELA Bio, Inc.

2026-09-17PurchaseCapper Joseph Hdirector
25,000
0.0529%
$1.22
$30,530
-16.28%
2026-09-16PurchaseCapper Joseph Hdirector
50,000
0.1104%
$1.17
$58,265
-8.05%
2026-09-15PurchaseCapper Joseph Hdirector
50,000
0.1086%
$1.06
$52,940
0.00%
2026-09-14PurchaseCapper Joseph Hdirector
25,000
0.0427%
$1.02
$25,503
+4.81%
2026-08-17PurchaseGetz Heather CChief Executive Officer
12,500
0.0223%
$0.66
$8,311
+51.00%
2026-08-14PurchaseGetz Heather CChief Executive Officer
15,000
0.0283%
$0.70
$10,467
+51.91%
2025-11-17PurchaseEW HEALTHCARE PARTNERS FUND 2, L.P.See Remarks
3.6M
8.8578%
$1.11
$4M
-23.69%
2024-10-24PurchaseKOBLISH ANTONYChief Executive Officer
88,888
0.325%
$2.25
$199,998
-26.55%
2024-10-24PurchaseCuca RobertoCOO and CFO
64,444
0.2356%
$2.25
$144,999
-26.55%
2024-10-24PurchaseTalmo PaulChief Technology Officer
22,222
0.0813%
$2.25
$50,000
-26.55%
2024-10-24PurchaseFirestone Gregory A.Chief Commercial Officer
6,666
0.0244%
$2.25
$14,999
-26.55%
2024-07-02SaleORBIMED ADVISORS LLC10 percent owner
36,600
0.1299%
$4.54
$166,164
-42.52%
2024-07-01SaleORBIMED ADVISORS LLC10 percent owner
13,700
0.0501%
$4.68
$64,116
-40.98%
2024-06-28SaleORBIMED ADVISORS LLC10 percent owner
378,000
1.4002%
$4.74
$1.79M
-43.62%
2023-12-05PurchaseFirestone Gregory A.Chief Business Officer
2,600
0.011%
$5.65
$14,688
-9.72%
2023-11-14PurchaseKOBLISH ANTONYChief Executive Officer
11,000
0.0454%
$4.54
$49,976
+9.47%
2023-11-14PurchaseCuca RobertoCOO and CFO
10,000
0.0408%
$4.49
$44,938
+9.47%
2023-04-21SaleORBIMED ADVISORS LLC10 percent owner
27,700
0.1432%
$9.41
$260,657
-24.76%
2023-04-20SaleORBIMED ADVISORS LLC10 percent owner
28,300
0.1502%
$9.43
$266,869
-22.68%
2023-04-19SaleORBIMED ADVISORS LLC10 percent owner
136,000
0.7142%
$9.30
$1.26M
-22.32%
Total: 184
*Gray background shows transactions not older than one year

Insider Historical Profitability

4.19%
EW HEALTHCARE PARTNERS FUND 2, L.P.See Remarks
7714709
17.0893%
$6.19M1180
+1.91%
Getz Heather CChief Executive Officer
532500
1.1796%
$427,065.0020
Capper Joseph Hdirector
179827
0.3983%
$144,221.2540
EW Healthcare Partners Fund 2-UGP, LLC
4105709
9.0948%
$3.29M250
+12.99%
ORBIMED ADVISORS LLC10 percent owner
2407242
5.3324%
$1.93M16
+2.92%
Opaleye Management Inc.director
1948000
4.3151%
$1.56M100
+27.85%
RTW INVESTMENTS, LP10 percent owner
1139358
2.5239%
$913,765.1211
+23.06%
Oliva Adele C
888664
1.9685%
$712,708.5310
+2.92%
Quaker BioVentures II LP10 percent owner
888664
1.9685%
$712,708.5310
+2.92%
KOBLISH ANTONYChief Executive Officer
458897
1.0165%
$368,035.3920
<0.0001%
Zuga Mattdirector
260808
0.5777%
$209,168.0210
+2.92%
Azarbarzin Kurtdirector
260808
0.5777%
$209,168.0210
+2.92%
Cuca RobertoCOO and CFO
155388
0.3442%
$124,621.1870
<0.0001%
Talmo PaulChief Technology Officer
91082
0.2018%
$73,047.7610
<0.0001%
Firestone Gregory A.Chief Commercial Officer
57279
0.1269%
$45,937.7620
<0.0001%
*Gray background shows insiders who have made transactions during last year

TELA Institutional Investors: Active Positions

Increased Positions19+46.34%6M+25.79%
Decreased Positions13-31.71%2M-8.73%
New Positions7New128,526New
Sold Out Positions5Sold Out2MSold Out
Total Postitions47+14.63%28M+17.06%

TELA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Nantahala Capital Management, Llc$5,827.0011.36%5.11M00%2025-09-30
Essex Woodlands Management, Inc.$4,686.009.14%4.11M00%2025-09-30
Silverarc Capital Management, Llc$3,173.006.18%2.78M+3,128+0.11%2025-09-30
Stonepine Capital Management, Llc$2,457.004.79%2.16M+71,757+3.44%2025-09-30
Vanguard Group Inc$2,052.004%1.8M-111,694-5.84%2025-09-30
Dafna Capital Management Llc$1,643.003.2%1.44M00%2025-09-30
Perkins Capital Management Inc$951.001.85%833,928-41,937-4.79%2025-09-30
Citigroup Inc$855.001.67%750,00000%2025-09-30
Velan Capital Investment Management Lp$852.001.66%747,41000%2025-09-30
Pentwater Capital Management Lp$826.001.61%724,856-90,144-11.06%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.